fbpx

Science

Study Title
Implication of non-alcoholic fatty liver diseases (NAFLD) in patients with COVID-19: a preliminary analysis
Publication
Journal of Hepatology
Author(s)

Dong Ji, Enqiang Qin, Jing Xu, Dawei Zhang, Gregory Cheng, Yudong Wang, George Lau

Abstract

Liver injury had been observed in COVID-19 patients with incidence ranging from 14–53%. We examined the liver injury patterns and implication of non-alcoholic fatty liver diseases (NAFLD) on clinical outcomes in Chinese with COVID-19.

Date
March 27, 2020
View study

Share This

Dr. Perlmutter is one of the leading lights in medicine today, illuminating the path for solving chronic illness

Mark Hyman, MD